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Abstract
Background: The treatment of patients with aortic regurgitation (AR) or mitral regurgitation (MR) relies on the 
accurate assessment of the severity of the regurgitation as well as its effect on left ventricular (LV) size and function. 
Cardiovascular Magnetic Resonance (CMR) is an excellent tool for quantifying regurgitant volumes as well as LV size 
and function. The 2008 AHA/ACC management guidelines for the therapy of patients with AR or MR only describe LV 
size in terms of linear dimensions (i.e. end-diastolic and end-systolic dimension). LV volumes that correspond to these 
linear dimensions have not been published in the peer-reviewed literature. The purpose of this study is to determine 
the effect of regurgitant volume on LV volumes and chamber dimensions in patients with isolated AR or MR and 
preserved LV function.
Methods: Regurgitant volume, LV volume, mass, linear dimensions, and ejection fraction, were determined in 34 
consecutive patients with isolated AR and 23 consecutive patients with MR and no other known cardiac disease.
Results: There is a strong, linear relationship between regurgitant volume and LV end-diastolic volume index (aortic 
regurgitation r2 = 0.8, mitral regurgitation r2 = 0.8). Bland-Altman analysis of regurgitant volume shows little 
interobserver variation (AR: 0.6 ± 4 ml; MR 4 ± 6 ml). The correlation is much poorer between regurgitant volume and 
commonly used clinical linear measures such as end-systolic dimension (mitral regurgitation r2 = 0.3, aortic 
regurgitation r2 = 0.5). For a given regurgitant volume, AR causes greater LV enlargement and hypertrophy than MR.
Conclusion: CMR is an accurate and robust technique for quantifying regurgitant volume in patients with AR or MR. 
Ventricular volumes show a stronger correlation with regurgitant volume than linear dimensions, suggesting LV 
volumes better reflect ventricular remodeling in patients with isolated mitral or aortic regurgitation. Ventricular 
volumes that correspond to published recommended linear dimensions are determined to guide the timing of 
surgical intervention.
Introduction
The timing of surgical intervention for patients with
mitral or aortic regurgitation often depends on the accu-
rate assessment of the severity of the valvular insuffi-
ciency and its effect on left ventricular (LV) size [1,2].
Two-dimensional transthoracic and transesophageal
e c h o c a r d i o g r a p h y  a r e  m o s t  c o m m o n l y  u s e d  t o  a s s e s s
mitral and aortic regurgitation. Published guidelines rec-
ommend the use of LV ejection fraction as well as linear
measurements such as LV end-diastolic dimension (EDD)
and LV end-systolic dimension (ESD) to determine the
timing of surgical interventions [2]. Cardiovascular mag-
netic resonance (CMR) is an accurate method for quanti-
fying the severity of mitral and aortic regurgitation [3-7].
CMR is more accurate and reproducible than two-dimen-
sional echocardiography in the three-dimensional volu-
metric evaluation of LV size and function [8-14]. An
important limitation of the current guidelines is that no
volumetric parameters are provided for determining the
timing of surgery and we currently rely on linear mea-
surements as a surrogate for describing LV volumetric
changes. The purpose of this study is to characterize the
physiological relationship between regurgitant volume
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and LV volume with CMR in patients with mitral and aor-
tic regurgitation.
Methods
Patient characteristics
This study was a retrospective analysis of patients
referred for a clinical CMR evaluation between 2006 and
2009. This study was approved by the Institutional
Review Board of St. Luke's and Roosevelt Hospitals. Con-
secutive patients were included provided 1) they had suf-
ficient mitral or aortic regurgitation to warrant
quantification of their regurgitant volume in their clinical
report and 2) phase contrast images of pulmonary artery
and aortic flow were acquired with a corresponding
phantom image for correcting baseline flow offsets [15].
Patients whose CMR studies showed other significant
cardiac abnormalities were excluded. Exclusion criteria
included: more than mildly abnormal ventricular func-
tion (LV EF < 50% or right ventricular EF < 40%), regional
ventricular wall motion abnormalities, more than right
ventricular (RV) enlargement (RV end-diastolic volume
index >115 ml/m2), myocardial ischemia or scar, left ven-
tricular hypertrophy, intracardiac shunt, more than mild
tricuspid or pulmonic regurgitation, and patients with an
irregular cardiac rhythm. Additionally, patients were
excluded from the mitral regurgitation (MR) group if they
had more than minimal (>10 ml) aortic regurgitation
(AR) and from the AR group if they had more than mini-
mal (>10 ml) MR. The analysis comprised 57 patients
who underwent CMR evaluation, and included 34
patients (62 ± 17 years, male 88%) with AR and 23
patients (55 ± 15 years, male 65%) with MR.
CMR image acquisition
Patients were imaged with a 1.5-Tesla scanner using an 8-
element, phased-array coil (GE Signa, EXCITE, GE Medi-
cal Systems, Milwaukee, Wisconsin, USA). Images were
acquired with ECG gating and breath holding. Short and
long axis cine images were acquired using a steady-state
free precession pulse sequence (FIESTA) with the follow-
ing parameters: TR/TE 3.3 ms/1.4 ms, 20 views per seg-
ment, FOV 35 × 35 cm, acquisition matrix 192 × 160,
slice thickness 8 mm, slice gap 0 mm, flip angle 45
degrees, receive bandwidth 125 kHz. Phase contrast
images were acquired perpendicular to the proximal pul-
monary artery and perpendicular to the proximal aorta to
quantify flow in these vessels using the following parame-
ters: TR/TE 7.5 ms/2.9 ms, 6 views per segment, Venc
250 cm/s, FOV 35 × 35 cm, acquisition matrix 256 × 128,
slice thickness 4 mm, flip angle 20 degrees, receive band-
width 31.3 kHz. After the clinical scan was completed,
additional phase contrast images were acquired of a sta-
tionary bottle of water (phantom) for baseline flow cor-
rection [15].
CMR image analysis
Images were reviewed and analyzed using ReportCard 4.0
software. LV volumes and mass were determined using
the semiautomated LV segmentation algorithm which
excludes papillary muscles and trabeculations from the
LV cavity and which uses a long axis image to define the
position of the LV base. RV volumes were determined by
manual segmentation of the short axis images. Aortic and
pulmonary artery flow values were determined using the
resident semiautomated algorithm. Correction for base-
line offsets was performed using a phantom phase con-
trast image as described previously [15]. In some patients
two or three flow acquisitions were made. In these cases,
the flow values were averaged. Aortic regurgitant volume
was determined by integrating blood flow throughout
diastole. Aortic and mitral regurgitant volume were
defined as per the AHA/ACC treatment guidelines: mild
< 30 ml, moderate 30-59 ml, and severe ≥60 ml. Mitral
regurgitant volume was determined as the difference
between the LV stroke volume (as determined by endo-
cardial segmentation) and total pulmonary artery flow.
Left atrial (LA) volumes were calculated using the area-
length method (LV volume = 0.85 *Area2/length) by aver-
aging values from the four and two chamber views. To
determine the reproducibility of AR and MR regurgitant
volume, a second blinded analysis was made according to
the same method.
Statistical analysis
All analyses were carried out using a standard statistical
package (SPSS Version 16.0, SPSS Inc., Chicago, Illinois).
Continuous variables were reported as mean ± SD and
categorical variables were reported as percentages. Cor-
relation between regurgitant volumes and left ventricular
measures and left atrial volumes were calculated using
Pearson's correlation coefficient. Interobserver variability
was measured using Bland-Altman analysis and Intrac-
lass Correlation Coefficient. P values were considered
significant at < 0.05.
Results
Aortic regurgitation
Demographic and CMR data of the patients with AR are
summarized in Table 1. Of the 34 patient studies with AR,
13 (38%) have mild AR, 10 (30%) have moderate AR, and
11 (32%) have severe AR. The mean aortic regurgitant
volume is 40 ± 27 ml. The mean LV ejection fraction is 64
± 7.5%. For patients with mild, moderate or severe AR,
the mean LV end-diastolic volume (EDVI) is 83 ± 13 ml/
m2(range = 61 - 100 ml/m2), 103 ± 13 (range = 82 - 121
ml/m2), and 146 ± 19 ml/m2(range = 125 - 186 ml/m2)
respectively. Figure 1 shows the relationships between
regurgitant volume and LV end-diastolic volume index
(EDVI), LV end-systolic volume index (ESVI), LV EDD,Uretsky et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:32
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and LV ESD. There is a strong, linear relationship
between aortic regurgitant volume and LV EDVI (r2 =
0.8). There are moderate, linear relationships between
aortic regurgitant volume and LV ESVI (r2 = 0.5), LV EDD
(r2 = 0.7), and LV ESD (r2 = 0.5). Linear regression is used
to determine the LV volumes that correspond to an LV
ESD of 55 mm and an LV EDD of 75 mm. These values
are listed in Table 2.
Mitral regurgitation
Demographic and CMR data of the patients with MR are
summarized in Table 1. Of the 23 patient studies with
MR, 9 (40%) have mild MR, 7 (30%) have moderate MR,
and 7 (30%) have severe MR. The mean mitral regurgitant
volume is 46 ± 34 ml. The mean LV ejection fraction is 72
± 6.4%. For patients with mild, moderate or severe MR
the mean LV EDVI is 75 ± 10 ml/m2(range = 62 - 89 ml/
m2), 94 ± 8 ml/m2(range = 82 - 107 ml/m2) and 119 ± 24
ml/m2(range = 98 - 167 ml/m2) respectively. Figure 2
shows the relationships between regurgitant volume and
LV EDVI, LV ESVI, LV ESD, and LA volume. There is a
strong, linear relationship between mitral regurgitant
volume and LV EDVI (r2 = 0.8). There is a moderate, lin-
ear relationship between mitral regurgitant volume and
LV ESVI (r2 = 0.5). There are weak linear relationships
between mitral regurgitant volume and LV ESD (r2 = 0.3)
and mitral regurgitant volume and LA volume (r2 = 0.3).
Li n ea r  r e gr es s i o n  is  us ed  t o  d e t e rm i n e  t h e  L V  v o l u m e
that corresponds to an LV ESD of 40 mm (shown in Table
2).
Interobserver agreement
Figure 3 shows strong interobserver agreement in the
quantification of AR. The mean ± SD for aortic regurgi-
tant volume was 39 ± 26 ml for observer 1 and 40 ± 26 ml
for observer 2 with a strong correlation (Intraclass Corre-
lation Coefficient = 0.99 95% CI 0.989 - 0.997, p < 0.0001).
For aortic regurgitant volume, Bland-Altman analysis
revealed a strong agreement between observer 1 and 2
with a mean difference of 0.6 ± 4 ml (95% CI -8.52 to 7.32
sml). Figure 3 also shows strong interobserver agreement
in the quantification of MR. The mean ± SD for mitral
regurgitant volume was 47 ± 32 ml for observer 1 and 43
± 32 ml for observer 2 with a strong correlation (Intrac-
lass Correlation Coefficient = 0.99 95% CI 0.95 - 0.99, p <
0.0001). For mitral regurgitant volume, Bland-Altman
analysis revealed a strong agreement between observer 1
and 2 with a mean difference of 4 ± 6 ml (95% CI -9 to 17
ml).
The relationship of LV EDVI and mass index to the type and 
severity of regurgitation
We found a greater increase in LV EDVI for a given
r e g u r g i t a n t  v o l u m e  i n  p a t i e n t s  w i t h  A R  c o m p a r e d  t o
those with MR (Figure 4). Furthermore, when comparing
mean LV mass index among patients with moderate and
severe regurgitation, those with AR had significantly
higher LV mass index than those with MR (Figure 5).
Mean LV mass index was significantly higher in patients
with severe AR vs. mild AR (118 ± 22 vs. 77 ± 17 g/m2, p <
0.0001) and severe MR vs. mild MR (92 ± 16 vs. 65 ± 20 g/
m2, p = 0.01).
Discussion
CMR has long been accepted as an accurate and repro-
ducible technique for evaluating LV size and function.
Good correlation has been obtained by comparing CMR
to other established techniques such as echocardiography
[11,16], contrast ventriculography [17], and radionuclide
imaging [18,19]. In addition, several groups of investiga-
tors have documented the accuracy of CMR for quantify-
ing regurgitant volumes in patients with AR or MR, again
by comparison to other imaging modalities such as
echocardiography [6,20-22] or cardiac catheterization
[5]. A problem with these comparative studies is that it
can be difficult to determine which of the two imaging
modalities is correct when the results differ, which they
inevitably do to at least some extent.
To our knowledge, this is the first CMR study to quan-
tify the physiologic relationship between regurgitant vol-
ume and chamber volume in patients with isolated
chronic AR or MR and preserved LV function. For both
Figure 1 Relationship Between Aortic Regurgitant Volume and 
(A) LV EDVI, (B) LV ESVI, (C) LV EDD, and (D) LV ESD. EDD: end-dia-
stolic dimension, EDVI: end-diastolic volume index, ESD: end-systolic 
dimension, ESVI: end-systolic volume index, LV: left ventricular.Uretsky et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:32
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AR and MR, we find a strong linear correlation between
regurgitant volume and LV EDVI (r2 = 0.8). This provides
an independent line of evidence supporting the accuracy
of MRI for quantifying regurgitant volume and ventricu-
lar volumes. We also find MRI is a robust technique. The
data show excellent interobserver variation for quantify-
ing regurgitant volume as demonstrated by the Bland-
Altman analysis which showed a mean difference of 0.6 ±
4 ml for AR and 4 ± 6 ml for MR.
In our patients with chronic mitral regurgitation, we
find the correlation between regurgitant volume and LV
EDVI is str onger t han wit h L V ESVI, pr oba bly in part
because additional factors influence LV ESVI, such as
myocardial contractility. The coupling between LV EDVI
and regurgitant volume is strong. An r2 of 0.8 implies 80%
o f  t h e  o b s e r v e d  v a r i a t i o n  i n  L V  v o l u m e  i s  d u e  t o  t h e
severity of the regurgitant volume. This implies that in
our patient population only 20% of the variation is related
to other factors such as differences in pre-load, afterload
o r  h e a r t  r a t e .  I t  i s  p o s s i b l e  t h a t  a n  a c u t e  p h y s i o l o g i c
change could weaken the coupling between regurgitant
volume and LV EDVI, because regurgitant volume is an
Table 1: Clinical and CMR data
Mitral Regurgitation (n = 23) Aortic Regurgitation (n = 34)
Age (years) 55 ± 15 62 ± 17
Male sex 15 (65%) 30 (88%)
Regurgitant volume (ml) 46 ± 34 40 ± 27
LV EF (%) 72 ± 6.4 64 ± 7.5
LV ESD (mm) 37 ± 4.9 42 ± 6.7
LV EDD (mm) 58 ± 5.8 60 ± 8.2
LV EDV (ml) 178 ± 56 215 ± 67
LV ESV (ml) 49 ± 18 76 ± 32
LV EDVI (ml/m2) 94 ± 23 109 ± 31
LV ESVI (ml/m2) 26 ± 8.0 39 ± 16
LV mass index (g/m2) 79 ± 21 96 ± 24
RV EF (%) 58 ± 8.4 59 ± 7.3
RV EDV (ml) 156 ± 40 156 ± 43
RV ESV (ml) 67 ± 30 64 ± 23
RV EDVI (ml/m2) 80 ± 16 78 ± 15
RV ESVI (ml/m2) 34 ± 12 33 ± 10
Values are n (%) or median ± standard deviation.
EDD: end-diastolic dimension, EDV: end-diastolic volume, EDVI: end-diastolic volume index, EF: ejection fraction, ESD: end-systolic dimension, 
ESV: end-systolic volume, ESVI: end-systolic volume index, LV: left ventricular, RV: right ventricle.
Table 2: Corresponding LV volumetric parameters to standard linear LV dimensions
LV Volume Index (ml/m2) LV Volume (ml)
Mitral Regurgitation
ESD = 40 mm ESVI: 29 ESV: 58
Aortic Regurgitation
ESD = 55 mm ESVI: 63 ESV: 127
EDD = 75 mm EDVI: 158 EDV: 324
EDD: end-diastolic dimension, EDVI: end-diastolic volume index, ESD: end-systolic dimension, ESV: end-systolic volume, ESVI: end-systolic 
volume index.Uretsky et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:32
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instaneous measure whereas LV EDVI is a more chronic
measure, and may better reflect the long term average
severity of regurgitation. It is interesting to note that LV
ESD, a parameter included in the AHA/ACC manage-
ment guidelines to guide therapy, correlates very poorly
with regurgitant volume (r2 = 0.2). Finally, left atrial vol-
ume, a parameter which is often used by the echocardio-
graphic community and which has been reported as a
reliable estimator of regurgitant volume [23], shows a rel-
atively poor correlation with regurgitant volume (r2 =
0.3).
In our patients with chronic AR, we find a stronger pos-
itive correlation with LV EDVI than with LV ESVI, again
probably in part because additional factors influence LV
ESVI, such as myocardial contractility. It is interesting to
note that for a given regurgitant volume, patients with AR
have more LV enlargement and a greater LV mass index
than patients with MR. This observation is likely due to
the nature of the hemodynamic stress placed on the LV;
whereas MR is a pure volume lesion AR is both a pressure
Figure 2 Relationship Between Mitral Regurgitant Volume and 
(A) LV EDVI, (B) LV ESVI, (C) LV ESD, and (D) Left atrial volume. EDD: 
end-diastolic dimension, EDVI: end-diastolic volume index, ESVI: end-
systolic volume index, LV: left ventricular.
Figure 3 Bland-Altman analysis of the Interobsever Agreement for the Measure of (A) Aortic and (B) Mitral Regugitant Volume. AR: aortic 
regurgitation, MR: mitral regurgitation.
Figure 4 Relationship Between of Aortic and Mitral Regurgitant 
Volume and LV EDVI. EDVI: end-diastolic volume index, LV: left ven-
tricular.Uretsky et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:32
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and a volume lesion [24]. Additionally, our data suggest
that the difference between the two regression lines
reflects the difference in afterload of the two patient
groups. As one expects, the two linear regression lines
approach the same value at a regurgitant volume of 0.
Commonly used linear measures such as LV EDD and LV
ESD showed a substantially worse correlation with regur-
gitant volume than volumetric measures such as LV
EDVI or LV ESVI. These finding are consistent with pre-
vious reports that a linear measurement does not always
accurately represent the actual volumetric changes of a 3-
dimensional structure such as the LV [25].
M a n y  o f  t h e  p a t i e n ts  i n  t h i s  s t u d y  w e r e  r e f e r r e d  f o r
CMR because the severity of the regurgitation could not
be accurately determined by echocardiography. The clini-
cal CMR reports included the regurgitant volume, LV
dimensions, and LV volumes. Unfortunately, the LV vol-
umes could not be used by the referring physician to
determine the timing of surgical intervention because the
AHA/ACC management guidelines only refer to linear
dimensions. However, the fact that the volumetric mea-
sures correlated better to the regurgitant volume than
corresponding linear measures suggests the possibility
that volumetric measures may be more valuable than lin-
ear measures in assessing the response of the left ventri-
cle to chronic MR or AR and in guiding the timing of
surgical intervention. It is our hope that the volumetric
correlates to the guideline dimensions which are listed in
Table 2 will provide a foundation for the inclusion of vol-
umetric data in future management guidelines.
Study limitations
Our data are retrospective in nature and only apply to
patients with normal or mildly decreased left ventricular
function and no other known cardiac disease. These data
may not be applicable to patients with other concurrent
cardiac diseases and/or LV dysfunction.
Conclusion
CMR is a robust technique for quantification of regurgi-
tant volume in patients with AR or MR and preserved LV
function. LV volumes show a stronger correlation with
regurgitant volume than the linear dimensions recom-
mended in the current management guidelines. These
data suggest that LV volumes better reflect ventricular
r e m o d e l i n g  i n  p a t i e n t s  w i t h  i s o l a t e d  m i t r a l  o r  a o r t i c
regurgitation.
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